Recent

% | $
Quotes you view appear here for quick access.

Coronado Biosciences, Inc. Message Board

thestockanalyst 11 posts  |  Last Activity: Aug 31, 2015 9:15 AM Member since: Mar 8, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • thestockanalyst thestockanalyst Jun 3, 2015 10:37 PM Flag

    Walter Schindler is a heavyweight the business world and has great vision and influence.
    The fact that he just joined BioLargo is proof enough that this technology is indeed very real and about to explode.

    His timing appears perfect.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Buy

  • Chart shows turnaround with big increase in volume and buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows clear bottom on very large volume.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    New management is very strong, capable and with strong healthcare relationships. New CEO and President already grew $1.3 Billion sales in previous company.

    Revenues set to explode again in 2015.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows clear bottom on very large volume.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    New management is very strong, capable and with strong healthcare relationships. New CEO and President already grew $1.3 Billion sales in previous company.

    Revenues set to explode again in 2015.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • The financial condition is horrible

    sales are horrible

    management is horrible

    no public relations

    no future

    company needs to sell shares soon to raise money that will drop prices below $1.00

    conclusion is Strong Sell

    Sentiment: Strong Sell

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Put shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Put shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Buy and hold these penny shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

CNDO
4.110.00(0.00%)Apr 23 3:59 PMEDT